GENERIC NAME OF THE MEDICINAL PRODUCT:
B) Amisulpride Sustained Release Tablets IP 200mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each uncoated sustained release tablet contains:
Amisulpride IP…………………100mg
Excipients……………………………q.s.
Colours: Sunset yellow aluminium lake
B) Amisulpride Sustained Release Tablets IP 200mg
Each uncoated sustained release tablet contains:
Amisulpride IP…………………200mg
Excipients……………………………q.s.
Colours: Ponceau 4 R
THERAPEUTIC INDICATIONS:
CAUTION & SCHEDULE:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
SCHEDULE: SCHEDULE H:TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A PSYCHIATRISTS ONLY.
STORAGE & DOSAGE:
Protect from Light and moisture.
Dosage: As directed by the Psychiatrist.
Amisulpride Sustained Release Tablets 200mg Technical Specification:
| Product Name: | Amisulpride Sustained Release Tablets IP |
| Brand Name: | Generic |
| Strength: | 100mg, 200mg |
| Dosage Form: | Tablets (Uncoated Sustained Release) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antipsychotic, Anti-Emetic |
| Indication: | Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting; and at higher doses by mouth to treat schizophrenia and acute psychotic episodes. |
| Storage: | Store below 30°C. Protect from Light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
A) Amisulpride Sustained Release Tablets IP 100mg
B) Amisulpride Sustained Release Tablets IP 200mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Amisulpride Sustained Release Tablets IP 100mg
Each uncoated sustained release tablet contains:
Amisulpride IP…………………100mg
Excipients……………………………q.s.
Colours: Sunset yellow aluminium lake
B) Amisulpride Sustained Release Tablets IP 200mg
Each uncoated sustained release tablet contains:
Amisulpride IP…………………200mg
Excipients……………………………q.s.
Colours: Ponceau 4 R
THERAPEUTIC INDICATIONS:
Amisulpride is an antiemetic and antipsychotic medication used at lower doses intravenously to prevent and treat postoperative nausea and vomiting; and at higher doses by mouth to treat schizophrenia and acute psychotic episodes.
CAUTION & SCHEDULE:
CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
SCHEDULE: SCHEDULE H:TO BE SOLD BY RETAIL ON THE PRESCRIPTION OF A PSYCHIATRISTS ONLY.
STORAGE & DOSAGE:
Storage: Store below 30°C.
Protect from Light and moisture.
Dosage: As directed by the Psychiatrist.
Amisulpride Sustained Release Tablets 200mg Manufacturer in India
Mental health disorders, particularly schizophrenia, are increasingly recognized as major global health challenges. Amisulpride Sustained Release Tablets 200mg play a crucial role in the long-term management of schizophrenia by helping patients achieve symptom stability and improved quality of life. As global demand for high-quality antipsychotic medications rises, Taj Pharma has established itself as a leading Amisulpride Sustained Release Tablets 200mg manufacturer, supplier, and exporter in India, trusted by healthcare systems and pharmaceutical partners worldwide.
Introduction to Amisulpride Sustained Release Tablets 200mg
Amisulpride Sustained Release Tablets 200mg are a prescription-only atypical antipsychotic medication primarily used in the treatment of schizophrenia. The drug is effective in managing both:
-
Positive symptoms such as hallucinations, delusions, and thought disorders
-
Negative symptoms such as emotional withdrawal, lack of motivation, and blunted affect
Amisulpride works by modulating the activity of specific chemical messengers (dopamine receptors) in the brain that influence perception, mood, and behavior. The sustained-release formulation ensures consistent therapeutic levels, improved patient compliance, and reduced dosing frequency.
Growing Global Demand
With rising awareness of mental health, expanding psychiatric care infrastructure, and increasing diagnosis rates, the global demand for Amisulpride Sustained Release Tablets 200mg is growing steadily across Asia, Africa, Latin America, the Middle East, and CIS regions. This trend has positioned India as a preferred manufacturing hub—and Taj Pharma as a reliable global supplier.
A Trusted Amisulpride Sustained Release Tablets 200mg Manufacturer in India
Taj Pharma is a well-known Amisulpride Sustained Release Tablets 200mg manufacturer in India, offering unmatched assurance of quality, purity, safety, and regulatory compliance. The company operates from Vapi, Gujarat, with strong commercial and logistics support from Mumbai, Maharashtra, enabling efficient PAN India and international supply.
Taj Pharma is a well-established Manufacturer, Exporter, and Supplier of Amisulpride Sustained Release Tablets 200mg, widely used in the treatment of schizophrenia and other psychotic disorders under medical supervision.
Therapeutic Uses, Dosage & Safety Information
Medical Uses
-
Schizophrenia (acute and chronic phases)
-
Management of positive and negative psychotic symptoms
Mechanism of Action
Amisulpride is an atypical antipsychotic that selectively blocks dopamine D2 and D3 receptors, helping normalize abnormal neurotransmission without excessive sedation.
Dosage & Administration
-
Usually taken once daily, preferably at bedtime to minimize daytime sleepiness
-
Must be taken strictly as prescribed by a psychiatrist or physician
Possible Side Effects
Some patients may experience:
-
Increased prolactin levels
-
Sleepiness
-
Blurred vision
-
Insomnia
-
Extrapyramidal symptoms
-
Hypotension (low blood pressure)
Patients should inform their doctor of any persistent or severe side effects.
In-Depth Details for Importers, Exporters & Buyers
Regulatory Documentation Provided
Taj Pharma offers comprehensive regulatory support, including:
-
WHO-GMP Certificate
-
Certificate of Pharmaceutical Product (COPP)
-
Free Sale Certificate (FSC)
-
Certificate of Analysis (COA)
-
Stability Study Reports
-
Product Specifications
-
CTD / eCTD Dossier Support
Custom Packaging & Labeling
-
Alu-Alu blister packaging
-
PVC blister packaging
-
HDPE container packaging
-
Private labeling and brand registration
-
Multilingual artwork as per importing country requirements
Shelf Life, Storage & Dosage Form
-
Dosage Form: Sustained Release Tablet
-
Strength: 200mg
-
Shelf Life: 24–36 months
-
Storage: Store below 25°C, protected from light and moisture
Export Certifications
-
WHO-GMP Certified Manufacturing Facility
-
ISO Certified Quality Systems
-
EU-GMP support (on request)
-
Complete export documentation compliance
Target Export Countries & Markets
Taj Pharma exports Amisulpride Sustained Release Tablets 200mg to:
Asia, Africa, Middle East, Latin America, CIS countries, and emerging European markets.
Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter
State-of-the-Art Manufacturing
-
Advanced sustained-release formulation technology
-
Dedicated psychotropic medicine manufacturing lines
-
In-house quality control and testing laboratories
Affordable Pricing & Quality Assurance
Taj Pharma ensures cost-effective pricing without compromising quality, making it ideal for:
-
Government tenders
-
Hospital procurement
-
Bulk pharmaceutical importers
-
PCD franchise partners
Global Presence & Supply Chain Support
-
Strong export logistics network
-
Timely delivery schedules
-
Dedicated international business team
Top 20 Exporting Countries
India , Bangladesh, Nepal, Sri Lanka, Vietnam, Philippines, Cambodia, Nigeria, Kenya, Ghana, Egypt, Ethiopia, Morocco, Peru, Colombia, Ecuador, Bolivia , Ukraine, Uzbekistan, Kazakhstan
Technical Product Specification Table
| Parameter | Details |
|---|---|
| Product Name | Amisulpride Sustained Release Tablets |
| Strength | 200mg |
| Dosage Form | Sustained Release Tablet |
| Therapeutic Class | Atypical Antipsychotic |
| Indication | Schizophrenia |
| Shelf Life | 24–36 Months |
| Storage | Below 25°C |
| Packaging | Blister / Bottle |
| Manufacturer | Taj Pharma Ltd, India |
| Certification | WHO-GMP, ISO |
PAN India Manufacturer & PCD Pharma Franchise Opportunity
Taj Pharma is a PAN India Amisulpride Sustained Release Tablets 200mg manufacturer and supplier, offering attractive PCD Pharma Franchise opportunities, including:
-
Monopoly rights
-
Marketing and promotional support
-
Assured supply chain
-
Competitive margins
Whether you are searching for an Amisulpride Sustained Release Tablets 200mg manufacturer in Mumbai, Vapi, Gujarat, or anywhere across India, Taj Pharma ensures reliable nationwide supply.
Call to Action
If you are looking for a reliable Amisulpride Sustained Release Tablets 200mg manufacturer, supplier, or exporter from India, Taj Pharma is your ideal long-term partner.
📞 Contact Taj Pharma today for bulk orders, international exports, regulatory support, private labeling, or PCD Pharma Franchise opportunities.
Top 20 FAQs
-
What is Amisulpride SR 200mg used for?
Treatment of schizophrenia. -
Is Taj Pharma WHO-GMP certified?
Yes. -
Is Amisulpride a prescription medicine?
Yes, strictly prescription-only. -
Can Taj Pharma export this product globally?
Yes, to more than 20 countries. -
What is the recommended dosing time?
Preferably at bedtime. -
Does it treat negative symptoms of schizophrenia?
Yes. -
What are common side effects?
Sleepiness, prolactin increase, hypotension. -
Is sustained-release better than immediate-release?
Yes, for compliance and stable levels. -
Does Taj Pharma offer private labeling?
Yes. -
What packaging options are available?
Blister and bottle packs. -
What is the shelf life?
24–36 months. -
Is EU-GMP documentation available?
On request. -
Does Taj Pharma support CTD dossiers?
Yes. -
Is PCD Pharma Franchise available?
Yes. -
Does Taj Pharma supply PAN India?
Yes. -
Where is Taj Pharma located?
Vapi, Gujarat & Mumbai, Maharashtra. -
Is COA provided with exports?
Yes. -
Can bulk orders be customized?
Yes. -
How should the tablets be stored?
Below 25°C, dry place. -
Why choose Taj Pharma?
Quality, compliance, pricing, and global trust.






